Mukka Proteins Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

3 hours ago
share
Share Via
At Rs 28.27, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mukka Proteins Ltd locked at its upper circuit of 5% on 21 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Mukka Proteins Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the BE series, hit its upper circuit price band of 5%, closing at Rs 28.27 after opening at Rs 28.23. The price band capped the daily gain at 5%, which means the rally was mechanically halted by exchange rules rather than a lack of buying interest. The intraday range was notably narrow, with the low at Rs 26.47 and the high fixed at the circuit price, reflecting the classic pattern where demand outstrips supply and the price ceiling freezes trading. This unfilled demand scenario is typical for stocks hitting upper circuits, especially in micro-cap segments where liquidity constraints amplify price moves. What does the full demand picture look like for Mukka Proteins once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Volume on the circuit day was 2.21 lakh shares, translating to a turnover of ₹0.61 crore. This volume is somewhat suppressed compared to typical trading days, a mechanical consequence of the circuit lock limiting price movement and thus trading activity. However, the delivery volume tells a more nuanced story. Delivery volume on 18 Sep was 58,440 shares but has fallen sharply by 89.43% against the 5-day average delivery volume, signalling a drop in shares taken for long-term holding on the immediate prior day. This decline in delivery volume on the circuit day suggests that while the price surged, the buying may have been driven more by short-term interest or speculative demand rather than strong conviction buying. Is Mukka Proteins' upper circuit move backed by genuine delivery-based buying or thin liquidity speculation?

Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.

  • - Consistent quarterly delivery
  • - Proven staying power
  • - Stability with growth

See the Consistent Performer →

Moving Averages and Trend Context

Mukka Proteins Ltd currently trades above its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bullish trend over the medium to long term. However, it remains below its 5-day moving average, suggesting some short-term consolidation or resistance. The upper circuit hit today can be seen as a breakout attempt supported by the broader trend structure. The weighted average price was closer to the low of the day, which may indicate that while the stock closed at the circuit high, much of the volume was executed at lower prices earlier in the session. This pattern often reflects a gradual build-up of buying interest culminating in a late surge to the circuit price.

Liquidity and Market Capitalisation Context

With a market capitalisation of approximately ₹818 crore, Mukka Proteins Ltd is classified as a micro-cap stock. Liquidity remains a critical consideration here: the stock is liquid enough for a trade size of just ₹0.09 crore based on 2% of the 5-day average traded value. This limited liquidity means that even modest buying or selling can cause significant price swings, and the upper circuit event must be viewed with caution. The thin order book typical of micro-caps can lead to exaggerated price moves that may not be sustainable once normal trading resumes. With near-zero liquidity and a micro-cap market cap, should investors be cautious about chasing Mukka Proteins at these levels?

Intraday Price Action

The stock opened with a gap up of 4.83% at Rs 28.23 and traded tightly around this level throughout the session, eventually hitting the upper circuit price of Rs 28.27. The narrow intraday range and the absence of any significant pullback highlight the strong buying pressure that pushed the stock to its ceiling early and kept it there. This pattern is typical for circuit hits where the price band restricts further upward movement, effectively locking in gains but also locking out late buyers who arrive after the price has reached the ceiling.

Fundamental Context

Mukka Proteins Ltd operates in the FMCG sector, a space known for steady demand and consumer staples. While the stock has shown a recent trend reversal after four consecutive days of decline, the fundamental backdrop remains steady without any extraordinary news driving the price spike. The outperformance today, with a 4.72% gain against the sector’s -0.23% and Sensex’s 0.29%, suggests the move is more technical and liquidity-driven than fundamentally triggered.

Mukka Proteins Ltd or something better? Our SwitchER feature analyzes this micro-cap FMCG stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Conclusion: Circuit, Delivery, and Liquidity Signals

The upper circuit hit at a 5% price band capped the gains for Mukka Proteins Ltd on 21 Sep 2026, reflecting strong buying interest that exceeded the maximum allowed daily price movement. However, the sharp fall in delivery volume compared to the recent average tempers the conviction narrative, suggesting that the surge may be driven more by speculative or short-term demand rather than sustained accumulation. The stock’s position above key moving averages supports a bullish trend, but the limited liquidity and micro-cap status introduce significant risk for investors attempting to enter or exit positions at these levels. The narrow intraday range near the circuit price further confirms the mechanical nature of the price lock rather than a broad-based rally.

Given these factors, after a 5% single-day gain at upper circuit, is Mukka Proteins still worth considering or has the move already happened?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)